Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Rossari Biotech Limited (NSE: ROSSARI), ISIN INE02A801020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ROSSARI last traded at ₹425.85 (-0.34%), with a 52-week range of ₹375.00 to ₹652.25 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 68.14%, FIIs 1.84%, DIIs 14.19%, mutual funds 9.11%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.